Filing Details
- Accession Number:
- 0001206386-12-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-09 17:06:23
- Reporting Period:
- 2011-12-02
- Filing Date:
- 2012-02-09
- Accepted Time:
- 2012-02-09 17:06:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899923 | Myriad Genetics Inc | MYGN | In Vitro & In Vivo Diagnostic Substances (2835) | 870494517 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1206386 | M Richard Marsh | 320 Wakara Way Salt Lake City UT 84108 | E.v.p., General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-12-02 | 1,000 | $0.00 | 14,005 | No | 4 | G | Direct | |
Common Stock | Acquisiton | 2012-02-07 | 6,019 | $5.89 | 20,024 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-02-07 | 6,019 | $24.00 | 14,005 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-02-07 | 6,667 | $24.04 | 0 | No | 4 | S | Indirect | by Fam. Ltd. Ptnrshp |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | G | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | by Fam. Ltd. Ptnrshp |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-02-07 | 6,019 | $0.00 | 6,019 | $5.89 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
43,981 | 2014-09-08 | No | 4 | M | Direct |
Footnotes
- The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.